1.4 TIME and MEASURE Assessment Frameworks

TIME and MEASURE Assessment Frameworks

Standardized clinical assessment frameworks remove subjective bias, streamline clinical communication, and guide targeted wound bed preparation (WBP). Two globally validated frameworks—TIME and MEASURE—provide clinical roadmaps for systematically identifying physiological deficits, implementing targeted interventions, and evaluating treatment efficacy over time.

---

The TIME Framework for Wound Bed Preparation

Developed by the International Wound Bed Preparation Advisory Board, the TIME framework addresses the four primary pathophysiological barriers to healing in chronic wounds.

  T - Tissue (Non-viable / Devitalized)  -----> Debridement Modalities
  I - Infection / Inflammation           -----> Antimicrobials & Biofilm Control
  M - Moisture Imbalance                -----> Absorbent or Hydrating Dressings
  E - Edge of Wound (Non-advancing)      -----> Advanced Therapies & Edge Debridement

1. T = Tissue Non-Viable or Defective

• Clinical Assessment: Identification of necrotic tissue, including moist yellow/tan slough, dry black eschar, or non-viable cellular debris covering the wound bed.
• Pathophysiology: Devitalized tissue acts as a mechanical barrier to cell migration, harbors pathogenic bacteria, and stimulates ongoing inflammatory protease release.
• Clinical Interventions: Debridement (sharp, enzymatic, autolytic, mechanical, biosurgical) to establish a clean, viable, vascular wound bed.

2. I = Infection or Inflammation

• Clinical Assessment: Evaluating bacterial bioburden across the continuum: Contamination $\rightarrow$ Colonization $\rightarrow$ Local Infection / Biofilm $\rightarrow$ Spreading Cellulitis / Systemic Infection.
• Pathophysiology: High bacterial burden and structured polymicrobial biofilms maintain chronic inflammatory cell infiltration, elevate MMP levels, and destroy growth factors.
• Clinical Interventions: Application of topical antimicrobials (cadexomer iodine, silver, medical-grade honey), mechanical biofilm disruption, or systemic antibiotics for spreading infection.

3. M = Moisture Imbalance

• Clinical Assessment: Evaluating exudate volume (scant, moderate, heavy) and tissue hydration.
• Pathophysiology: Desiccation causes cell death and halts keratinocyte migration. Conversely, excessive exudate contains corrosive MMPs that cause periwound maceration and tissue breakdown.
• Clinical Interventions: Restoring moisture balance. Use hydrating hydrogels for dry wound beds; utilize alginates, hydrofibers, foams, or Negative Pressure Wound Therapy (NPWT) for heavily exuding wounds.

4. E = Edge of Wound Non-Advancing or Epibolic

• Clinical Assessment: Inspecting wound margins for epithelial movement, rolled edges (epibole), hyperkeratosis, or lack of contraction.
• Pathophysiology: Stalled epithelial margins indicate senescent basal keratinocytes, matrix breakdown, or lack of dermal support.
• Clinical Interventions: Re-evaluate underlying etiology, cross-hatch or debride wound edges, and apply advanced therapies such as Cellular and Tissue-Based Products (CTPs/skin substitutes) or recombinant growth factors.

---

The MEASURE Framework for Comprehensive Assessment

The MEASURE framework provides an expanded 7-point clinical acronym for initial assessment and ongoing documentation.

---

Standardized Measurement Protocol: The Clock Method

To ensure inter-rater reliability, all linear wound dimensions must be measured using the standardized Clock Method with a flexible measuring tape and sterile applicator probe calibrated in centimeters.

                      12:00 (Head)
                           |
             09:00 <-------+-------> 03:00 (Right)
            (Left)         |
                      06:00 (Feet)

Rules of the Clock Method

1. Orientation: 12:00 is ALWAYS toward the patient's head, and 6:00 is ALWAYS toward the patient's feet, regardless of patient position (supine, prone, lateral) or anatomical site.
2. Length ($L$): Measured at the longest aspect parallel to the head-to-toe axis (12:00 to 6:00).
3. Width ($W$): Measured at the widest aspect perpendicular to length along the side-to-side axis (9:00 to 3:00).
4. Depth ($D$): Measured by inserting a sterile cotton-tipped applicator into the deepest point of the wound bed, marking the level of intact skin margin, and measuring against a centimeter ruler.
5. Surface Area Calculation: $\text{Surface Area } (cm^2) = \text{Length } (cm) \times \text{Width } (cm)$.

Differentiating Undermining vs. Tunneling (Sinus Tract)

• Undermining: Destruction of subcutaneous tissue extending horizontally under intact skin along the wound perimeter. Documented by noting the clock positions involved and maximum depth (e.g., "Undermining extending 2.5 cm from 1:00 to 5:00").
• Tunneling (Sinus Tract): A narrow channel or tract extending from any part of the wound bed through soft tissue in any direction, terminating in a dead space. Documented by noting exact clock direction and depth (e.g., "Sinus tract at 3:00 extending 4.2 cm").

  UNDERMINING (Wide lip under margin)         TUNNELING (Narrow deep tract)
  +---------------------------------+        +---------------------------------+
  | Intact Skin     Intact Skin     |        | Intact Skin     Intact Skin     |
  |  /===========\   /===========\  |        |  |             \               |  |
  | (  Undermined ) (  Undermined ) |        |  |  Wound Bed   \ Tunnel      |  |
  |  \___________/   \___________/  |        |  |____________   \=========>   |  |
  +---------------------------------+        +---------------------------------+

Re-evaluation Benchmarks & Healing Trajectory

Standardized framework guidelines mandate formal wound re-evaluation at least every 7 to 14 days.

Percent Area Reduction (PAR) as a Predictive Benchmark

Percent Area Reduction calculates healing trajectory:

$\text{PAR } (\%) = \frac{\text{Initial Area} - ext{Current Area}}{\text{Initial Area}} \times 100$

Clinical trials demonstrate that achieving 20% to 40% Percent Area Reduction (PAR) within 2 to 4 weeks of initiating optimal, etiology-specific care is highly predictive of complete healing by 12 to 24 weeks. If a chronic wound fails to achieve this minimum benchmark by 4 weeks, the clinician MUST formally re-evaluate the treatment plan, re-examine diagnostic assumptions (vascular status, biopsy for malignancy), and escalate to advanced therapeutic modalities.